Aspiro Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Aspiro Therapeutics is developing a novel peptidomimetic therapy that mimics the protective power of CC16, a natural lung protein essential for healthy breathing. Our lead product targets the underlying mechanisms of obstructive lung diseases like COPD and asthma, aiming to restore lung function and prevent disease progression.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}